By Delilah Alvarado Published September 8, 2026 The biotechnology landscape experienced a seismic shift this week as...
Chemotherapy and Targeted Therapy
In the ongoing war against infectious disease, medical science has historically relied on a "one bug, one...
For decades, the field of oncology has grappled with a persistent, debilitating side effect that haunts cancer...
The meteoric rise of GLP-1 receptor agonists—the class of drugs that includes blockbusters like Ozempic, Wegovy, and...
The landscape of modern pharmacology shifted fundamentally in May 2026. With the U.S. Food and Drug Administration’s...
The U.S. Department of Health and Human Services (HHS) has officially issued a solicitation for nominations to...
As the field of psychedelic medicine transitions from experimental curiosity to a potential pillar of mainstream psychiatry,...
This is the second installment in a new series where BioPharma Dive uses data visualization to recap...
The biotechnology sector in 2026 has entered a period of extraordinary maturation, characterized by a fundamental shift...
The landscape of clinical research is undergoing a seismic shift. As the industry races to develop life-saving...
